The Business Research Company’s Drug Screening Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Drug Screening Global Market Report 2023 evaluates drug screening market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id= =smp [FSG1]
The global drug screening market size grew from $6.62 billion in 2022 to $7.51 billion in 2023 at a compound annual growth rate (CAGR) of 13.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The drug screening market size is expected to grow to $12.29 billion in 2027 at a CAGR of 13.1%.
The drug screening market segments in the report are:
1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges
Get More Information On The Drug Screening Market Report:
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report
The table of contents in TBRC’s drug screening market report includes:
1. Executive Summary
2. Drug Screening Market Characteristics
3. Drug Screening Market Trends And Strategies
4. Drug Screening – Macro Economic Scenario
5. Drug Screening Market Size And Growth.
…..
27. Drug Screening Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Drug Screening Market
29. Drug Screening Market Future Outlook and Potential Analysis
30. Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Global Drug Screening Market was valued at US$ 4.10 Bn in 2019 and is expected to reach US$ 12.80 Bn by 2026, at a CAGR of 15.29 % during a forecast period.The Drug Screening Market Size 2021-2027 provides detailed competitive analysis, including market share, size, future scope, and future outlook.
Companies are investing heavily in new electric mopeds and scooters to make them more efficient.Get a Sample PDF of the Report at : Request Free Sample ReportList Of TOP KEY PLAYERS in Drug Screening Market Report are - • Mpd Inc.• Omega Laboratories• Premier Biotech• Psychemedics• Roche• Shimadzu• Siemens Healthineers• Labcorp• Quest Diagnostics• Alere• Orasure• Alfa Scientific Designs• Drägerwerk• Thermo Fisher Scientific• Drägerwerk• American Bio Medica Corporation• Sciteck, Inc.• Acm Global Laboratories• Carehealth America• Clinical Reference LaboratoryCOVID-19 Impact on Market:In December 2019, the COVID-19 epidemic began in Wuhan (China), and has been spreading rapidly around the world.
Due to travel bans and lockdowns, the COVID-19 epidemic has affected many countries' economies and industries.
This outbreak has caused major disruptions in the global food and drink industry, including supply chain breakdowns, cancellations of technology events, and office closures.
Segment by Application, The Drug Screening Market is divided into the United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
This report includes all aspects of the industry and a study of key players, including market leaders, followers, as well as new entrants.
Drug screening is the process of chemical analysis designed to test patients for drug abuse and to test the use of drugs and substances that are not permitted in specific occupations or athletic competitions.The drug screening market based on products and services has been divided into drug screening products and drug screening services.
Based on sample type is segmented into the urine, breath, oral fluid, hair, and other samples.
The market based on end-users has been divided into workplaces, criminal justice systems, and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories.
The workplace testing segment is expected to be one of the major contributors to the market.For More Information Visit https://www.maximizemarketresearch.com/market-report/drug-screening-market/1352/ Geographically, North America is expected to be one of the largest markets for drug screening.
The growth in this region is attributed to factors such as increasing consumption of illicit drugs, government funding for curb drug abuse and the laws for supporting drug screening.The years that have been considered are:• Base year – 2016• Estimated year – 2017• Forecast period – 2016 to 2026Key Highlights:• Drug screening market analysis and forecast, in terms of value.• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the drug screening market.• Drug screening market segmentation on the basis product & services, sample type, end-user and geography (country-wise) has been provided.• Drug screening market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of the study.• Drug Screening market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the drug screening market are also profiled.Research Methodology:The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market.
KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market.
Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period.Browse 204 market data Tables and 42 Figures spread through 203 Pages Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773The global Drug Screening Market is Segmented on:1.
End UserBreathalyzers are expected to dominate the drug screening products market in 2017.Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables.
In 2017, the breathalyzers segment is expected to dominate the market.
Growing alcohol consumption and drunken driving cases, stringent government laws mandating drug and alcohol testing, and technological advancements in this market are some of the key factors driving the growth of the breathalyzers market.Based on sample type, the oral fluid segment is projected to grow at the highest CAGR during the forecast period.By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples.
Among these the oral fluid segment is expected to register the highest CAGR during the forecast period.
The high growth of this segment is attributed to the increasing preference for oral fluid samples because of the convenient collection method, no specific requirement for sample collection, and low risk of sample adulteration.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773Regional Analysis:In 2017, North America is expected to dominate the market followed by Europe.
